Comparing Dulaglutide vs Liraglutide
Dulaglutide | Liraglutide |
|
---|
Dulaglutide | Liraglutide |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Dulaglutide mimics the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It lowers blood glucose levels in people with... View more |
Prescription only
Liraglutide (brand name Victoza) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Related suggestions Weight Loss (Obesity/Overweight)
Type 2 Diabetes
Cardiovascular Risk Reduction
|
|||||||
More about Dulaglutide | More about Liraglutide | ||||||||
Ratings & Reviews | |||||||||
Dulaglutide has an average rating of 5.3 out of 10 from a total of 993 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 40% reported a negative effect. |
Liraglutide has an average rating of 7.5 out of 10 from a total of 2330 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Dulaglutide side effects |
View all Liraglutide side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Liraglutide prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Trulicity | Saxenda, Victoza | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
120 hours |
13 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Victoza
Category X
Not for use in pregnancy
Saxenda See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 271 drugs are known to interact with Dulaglutide:
|
A total of 274 drugs are known to interact with Liraglutide:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 18, 2014 |
January 25, 2010 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Repatha
Repatha (evolocumab) is a PCSK9 inhibitor used to lower high cholesterol alongside dietary changes ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.